US 8217048
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted A61KA61K31/4178A61K31/4439
Quick answer
US patent 8217048 (Inhibitors of serine proteases, particularly HCV NS3-NS4A protease) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 38
- CPC classes
- A61K, A61K31/4178, A61K31/4439, A61K31/497, A61K31/501